Some recent updates from Somnair, a startup company tackling the incomplete market for effective treatments to sleep apnea cofounded and led by CBID alumni Mitchell Turley and Anders Sideris! Somnair recently took the stage at LSI USA 2026, sharing more about their company mission, and development of the first-in-class non-invasive neuro-stimulation solution to sleep apnea, a solution to the root of the problem.

This event was a great opportunity for Somnair to elaborate on their efforts , development and progress to an expansive network of industry leaders, investors, fellow entrepreneurs, and executives leading emergent medical technology companies. The program at LSI offers attendees valuable insight into the business, regulatory, and intellectual property considerations impacting medical device development and commercialization – providing important context for advising clients across the MedTech ecosystem.

Check them out:
https://lnkd.in/eZJpyMiT
https://lnkd.in/eB7x_chx

More on LSI
https://lnkd.in/dw_teTUK

More on Somnair:
https://lnkd.in/eqJ8yzw2